Pharmaceuticals, Biotechnology and Life Sciences
Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA…
Etan Bendheim assumes role of CEO and Mark Warner moves to CTO role Liberation Bioindustries Announces New Roles for Founders…
HUNTSVILLE, Jan. 15, 2026 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company…
All resolutions passed, enabling the Company to streamline regulatory and operational processesSAN DIEGO, Jan. 15, 2026 (GLOBE NEWSWIRE) — Oncolytics…
New York City, NY, Jan. 15, 2026 (GLOBE NEWSWIRE) — As metabolism supplements continue to grow in popularity in 2026,…
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE15 JANUARY 2026 at 16:30…
CHARLOTTE, N.C., Jan. 15, 2026 (GLOBE NEWSWIRE) — Adaptin Bio, Inc. (“Adaptin” or the “Company”), a biotechnology company focused on…
The Science, Clinical Promise, & Market OutlookMELBOURNE, Australia, Jan. 15, 2026 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc”…
GT Biopharma targets a portion of the estimated $362 billion global solid tumor market Preliminary, unaudited cash balance of approximately…
Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no…